To answer that question we have Gene Dodaro. He is the eighth Comptroller General of the United States—that means he is the head of the U.S. Government Accountability Office (GAO). He has held that ...
This story was originally published by ProPublica. ProPublica is a nonprofit newsroom that investigates abuses of power.
Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the new results of an international Phase III ...
In the spring of 2024, the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later, the Pfizer ...
Gavin Bowen-Metcalf does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
NIH study is trying to find answers. BAR HARBOR, Maine, Aug. 1, 2008— -- With new genetic testing available, researchers can calculate whether you have an increased risk for diabetes, breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback